SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Published on January 4, 2025

having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities